C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 498/10 (2006.01) A61K 31/435 (2006.01) C07D 498/20 (2006.01)
Patent
CA 2087529
2087529 9201690 PCTABS00010 Compounds of general formula (I), wherein: A represents (CH2)m optionally substituted by R3, B represents (CH2)n optionally substituted by R4, R1 represents hydrogen, C1-C6 alkyl, C3-6 alkenyl or C3-6 alkynyl, R2 represents hydrogen, C1-6 alkyl or COOR5, in which R5 represents C1-C6 alkyl, R3 and R4 independently represent hydrogen or C1-C6 alkyl, n and m independently represent an integer from 1-3 inclusive, Y represents O or S, provided that, any two of R2, R3 and R4 may together form a C1-3 alkylene chain, and pharmaceutically acceptable derivatives thereof are useful as pharmaceuticals, in particular as central muscarinic acetylcholine receptor agonists. The compounds are therefore useful in the treatment of neurological disorders such as presenile and senile dementia, Huntington's chorea, tardive dyskinesia, hyperkinesia, mania and Tourette Syndrome.
Kover Alexander
Wu Edwin S.
Fisons Corporation
Kover Alexander
Ridout & Maybee Llp
Wu Edwin S.
LandOfFree
Spiro-isoxazolidine derivatives as cholinergic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Spiro-isoxazolidine derivatives as cholinergic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spiro-isoxazolidine derivatives as cholinergic agents will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2025846